A data monitoring committee recommended stopping FLASH2, a randomized double-blind placebo-controlled confirmatory phase 3 ...
As Barry Russo, MBA, the longtime CEO of the Center for Cancer and Blood Disorders, described paying for the practice’s first ...
The country's energy storage sector is racing toward bigger batteries. But as capacity climbs, so do questions over safety, ...
Aging and cancer are deeply intertwined: advancing age is the single largest risk factor for most malignancies, and many of the molecular processes that ...
AI could "give the scientific community a way to address the most difficult and urgent questions in human health," argues ...
(TP53), widely known as the “guardian of the genome,” is one of the most frequently altered genes in human cancer. While its canonical tumor-suppressive ...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing ...
Chinese battery giants are increasingly adding sodium-ion cells to their stack – but what can they actually deliver?
The two companies announced a 60 GWh supply agreement on Monday, marking a pivotal step in the commercialization of sodium-ion battery technology.
Proteomics uncovered nearly 200 proteins that fluctuate across the menstrual cycle, offering new clues into reproductive ...
CDKs are central regulators of cell-cycle progression in cancer, with resistance to CDK4/6 inhibitors frequently converging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results